Autologous GPC3 CAR-T Cells (CBG166)

GPC3-targeted CAR-T cell therapy · Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous GPC3 CAR-T Cells (CBG166), covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma [Phase 1]